Viewing nowKrezid 5 mg (Rosuvastatin Calcium)
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Samik Pharmaceutical Co., Ltd.

MFDS item code 201503218 · Approved 2015.05.27 · Insurance code 644003660
Improvement of dyslipidemia, reduction of cardiovascular risk, and inhibition of atherosclerosis progression
This medication is used in patients with hypercholesterolemia and hyperlipidemia and is used as an adjunct when dietary therapy and exercise do not control it. It is especially effective in patients with familial hypercholesterolemia or dysbetalipoproteinemia, lowering total cholesterol and LDL cholesterol levels to delay the progression of atherosclerosis. Additionally, it helps reduce blood lipid levels in pediatric patients with specific conditions. This medication also reduces the risk of cardiovascular disease, particularly in middle-aged patients with elevated high-sensitivity C-reactive protein levels and cardiovascular risk factors, contributing to the reduction of the risk of stroke, myocardial infarction, and arterial revascularization. Thus, this medication is used for improving blood lipids and preventing cardiovascular diseases.
1. Primary hypercholesterolemia (type IIa), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is required, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which controls the condition in most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or longer according to LDL cholesterol levels, treatment goals, and patient response; the dose may be increased to a maximum of 20 milligrams daily. 2. Older adults: No dosage adjustment is necessary. 3. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering 20mg of this medicine to patients with moderate renal impairment. 4. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or less, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Assessment of renal function should be considered in these patients. There is no experience with administration in patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 5. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of the 40-milligram dose is contraindicated. 6. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of the 40-milligram dose is contraindicated in some of these patients.
This medication should not be administered to certain patients. For example, it should not be used in patients who are allergic to this medication or have severe liver dysfunction, patients with muscle diseases, patients with very poor renal function, or women who are pregnant or breastfeeding. Additionally, this medication may cause muscle-related side effects, so patients at high risk of myalgia or myopathy should use it cautiously and consult a doctor immediately if any unusual muscle symptoms occur during treatment. Patients with impaired liver function or those who consume alcohol excessively should undergo liver function tests before using this medication and should have regular liver function tests during treatment. This medication may increase blood glucose levels in some patients, so those at risk of diabetes should monitor their blood sugar regularly. Moreover, this medication may act differently in the body based on certain genetic factors, so dosage adjustment may be necessary based on the patient's condition. Severe skin reactions may occur, so if any symptoms such as skin rash or severe itching appear, the use of the drug should be stopped immediately and medical advice should be sought. This medication may interact with other drugs, so it is essential to inform the physician or pharmacist about any medications currently being taken, especially when combined with drugs that may affect the muscles. Women who are pregnant or planning to become pregnant should consult a specialist before using this medication and must use appropriate contraception. In the event of overdose, there is no specific antidote, so it is essential to visit a medical institution immediately and receive appropriate treatment while closely monitoring liver function and muscle status. This medication is known not to have a significant impact on the ability to drive or operate machinery, but caution should be taken as dizziness may occur after dosing.
Angioedema, hypersensitivity reaction, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, memory loss, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, ophthalmoplegia, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, eosinophilia, drug reaction with eosinophilia and systemic symptoms (DRESS), drug-induced pemphigus, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, liver failure, cognitive impairment, elevated ALT, chest pain, muscle cramps, gout, erectile dysfunction, elevated AST, numbness, dysesthesia, chest discomfort, loss of appetite, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. It is best to maintain the storage temperature between 1 degree and 30 degrees Celsius at room temperature. This helps retain the medication's efficacy for a longer duration.
Yellow round film-coated tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowRosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Samik Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.